Sleep and circadian rhythm regulation in early parkinson disease

JAMA Neurology

Volumn 71, Issue 5, 2014, Pages 589-595

  Breen, David P ^a   Vuono, Romina ^a   Nawarathna, Upekshani ^b   Fisher, Kate ^a   Shneerson, John M ^b   Reddy, Akhilesh B ^c   Barker, Roger A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MELATONIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CLOCK GENE; COHORT ANALYSIS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUALITY OF LIFE; REM SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY;

AGED; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 84900478730     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.65     Document Type: Article

References (33)

1. Barone P, Antonini A, Colosimo C, et al; PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinsons disease. Mov Disord. 2009;24(11):1641-1649.
2. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8(5):464-474.
3. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517-549.
4. Schmutz I, Ripperger JA, Baeriswyl-Aebischer S, Albrecht U. The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors. Genes Dev. 2010;24(4):345-357.
5. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649-661.
6. Boivin DB, James FO,Wu A, Cho-Park PF, Xiong H, Sun ZS. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood. 2003;102(12):4143-4145.
7. James FO, Boivin DB, Charbonneau S, Belanger V, Cermakian N. Expression of clock genes in human peripheral blood mononuclear cells throughout the sleep/wake and circadian cycles. Chronobiol Int. 2007;24(6):1009-1034.
8. Iber C, Ancoli-Israel S, Chesson A, Quan SF; American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications.Westchester, IL: American Academy of Sleep Medicine; 2007.
9. Hogl B, Arnulf I, Comella C, et al. Scales to assess sleep impairment in Parkinsons disease: critique and recommendations. Mov Disord. 2010;25(16):2704-2716.
10. Aarsland D, Bronnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinsons disease. J Neurol Neurosurg Psychiatry. 2009;80(8):928-930.
11. Martinez-Martin P, Falup Pecurariu C, Odin P, et al. Gender-related differences in the burden of non-motor symptoms in Parkinsons disease. J Neurol. 2012;259(8):1639-1647.
12. Schenck CH, Boeve BF, MahowaldMW. Delayed emergence of a parkinsonian disorder or dementia in 81%of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16 year update on a previously reported series. Sleep Med. 2013;14(8):744-748.
13. Trotti LM, Bliwise DL. No increased risk of obstructive sleep apnea in Parkinsons disease. Mov Disord. 2010;25(13):2246-2249.
14. Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol. 2007;9(5):347-353.
15. Breen DP,Williams-Gray CH, Mason SL, Foltynie T, Barker RA. Excessive daytime sleepiness and its risk factors in incident Parkinsons disease. J Neurol Neurosurg Psychiatry. 2013;84(2):233-234.
16. Peeraully T, Yong MH, Chokroverty S, Tan EK. Sleep and Parkinsons disease: a review of case-control polysomnography studies. Mov Disord. 2012;27(14):1729-1737.
17. Bus̃kova J, Klempi? J, Majerova V, et al. Sleep disturbances in untreated Parkinsons disease. J Neurol. 2011;258(12):2254-2259.
18. Yong MH, Fook-Chong S, Pavanni R, Lim LL, Tan EK. Case control polysomnographic studies of sleep disorders in Parkinsons disease. PLoS One. 2011;6(7):e22511.
19. Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J. Progressive sleep destructuring in Parkinsons disease: a polysomnographic study in 46 patients. Sleep Med. 2005;6(4):313-318.
20. Nakamura TJ, NakamuraW, Yamazaki S, et al. Age-related decline in circadian output. J Neurosci. 2011;31(28):10201-10205.
21. Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimers disease. J Pineal Res. 2005;38(3):145-152.
22. Langston JW, Forno LS. The hypothalamus in Parkinson disease. Ann Neurol. 1978;3(2):129-133.
23. Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinsons disease: an in vivo 11C-raclopride PET study. Exp Neurol. 2008;214(1):112-116.
24. Kudo T, Loh DH, Truong D,Wu Y, Colwell CS. Circadian dysfunction in a mouse model of Parkinsons disease. Exp Neurol. 2011;232(1):66-75.
25. Hartmann A, Veldhuis JD, DeuschleM, Standhardt H, Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimers and Parkinsons disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging. 1997;18(3):285-289.
26. Bordet R, Devos D, Brique S, et al. Study of circadian melatonin secretion pattern at different stages of Parkinsons disease. Clin Neuropharmacol. 2003;26(2):65-72.
27. Fertl E, Auff E, Doppelbauer A,Waldhauser F. Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J Neural Transm Park Dis Dement Sect. 1993;5(3):227-234.
28. Kunz D, Mahlberg R, Muller C, Tilmann A, Bes F. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials. J Clin Endocrinol Metab. 2004;89(1):128-134.
29. Srinivasan V, Cardinali DP, Srinivasan US, et al. Therapeutic potential of melatonin and its analogs in Parkinsons disease: focus on sleep and neuroprotection. Ther Adv Neurol Disord. 2011;4(5):297-317.
30. Cai Y, Liu S, Sothern RB, Xu S, Chan P. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinsons disease. Eur J Neurol. 2010;17(4):550-554.
31. Yujnovsky I, Hirayama J, Doi M, Borrelli E, Sassone-Corsi P. Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK: BMAL1. Proc Natl Acad Sci U S A. 2006;103(16):6386-6391.
32. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377.
33. Kondratova AA, Kondratov RV. The circadian clock and pathology of the aging brain. Nat Rev Neurosci. 2012;13(5):325-335.